Biotech Acquisition Co

Overview

• IndustryBlank Checks¹
• HeadquartersNew York, New York¹
• Incorporated inCayman Islands³
• Business address545 West 25Th Street, 20Th Floor, New York, Ny 10001³
• Filer category, Emerging growth company³

See how the biggest companies compare on our leaderboards

Corporate structure

Biotech Acquisition Co sits at the top of its group. 1 entity, 1 country on record. Switch between the flow chart and the network, and select any entity to see its details.

Built from major holders from Schedules 13D and 13G. Each entity in the chart links to its source.

What it owns

What Biotech Acquisition Co reports owning in its annual reports to the SEC: buildings, land and equipment, real estate and locations, investments, intangible assets and inventory, at the end of its latest fiscal year and a year before.

Investments

Leadership

Who has led Biotech Acquisition Co, and when. Pick a name to see everywhere that person has worked.

• Chief executive officerMichael Schleifer Jan 25, 2021 to Jan 25, 2021⁷
• Chief financial officerThomas Fratacci Jan 25, 2021 to Jan 25, 2021⁸
• Chief operating officerIvan Jarry Jan 25, 2021 to Jan 25, 2021⁹

Former names

• Biotech Acquisition CompanySep 21, 2020 to Sep 21, 2020³

Timeline

1. Feb 2, 20238-K Ended a material agreement; Other events¹³
2. Jan 25, 20238-K Shareholder vote; Other events¹⁴
3. Jan 11, 20238-K Listing notice or transfer¹⁵
4. Dec 22, 20228-K Entered a material agreement¹⁶
5. Oct 11, 20228-K Entered a material agreement; New debt or obligation¹⁷
6. Jun 17, 20228-K Shareholder vote¹⁸
7. Jun 13, 20228-K Entered a material agreement; Ended a material agreement; Other events¹⁹
8. Jun 3, 20228-K Regulation FD disclosure²⁰
9. May 31, 20228-K Regulation FD disclosure²¹
10. May 23, 20228-K Entered a material agreement²²
11. May 18, 20228-K Regulation FD disclosure²³
12. May 17, 20228-K Regulation FD disclosure²⁴
13. Jan 25, 2021New chief executive Michael Schleifer becomes CEO⁷

Filings

95 filings to the SEC since October 2021: 1 annual reports, 4 quarterly reports, 23 major events, 13 large holders, 54 other. The latest 20:

1. Feb 14, 2024SC 13G/A EDGAR
2. Feb 14, 202315-12G NOTICE OF TERMINATION OF REGISTRATION EDGAR
3. Feb 14, 2023SC 13G EDGAR
4. Feb 14, 2023SC 13G/A EDGAR
5. Feb 13, 2023SC 13G/A EDGAR
6. Feb 13, 2023SC 13G/A EDGAR
7. Feb 2, 20238-K CURRENT REPORT EDGAR
8. Jan 27, 2023SC 13G EDGAR
9. Jan 25, 2023SC 13G BIOT 13G EDGAR
10. Jan 25, 20238-K CURRENT REPORT EDGAR
11. Jan 11, 20238-K CURRENT REPORT EDGAR
12. Jan 4, 2023DEF 14A PROXY STATEMENT EDGAR
13. Dec 22, 20228-K CURRENT REPORT EDGAR
14. Dec 21, 2022PRE 14A PRELIMINARY PROXY STATEMENT EDGAR
15. Nov 22, 202210-Q QUARTERLY REPORT EDGAR
16. Nov 14, 2022NT 10-Q NOTIFICATION OF LATE FILING EDGAR
17. Oct 11, 20228-K CURRENT REPORT EDGAR
18. Aug 22, 202210-Q QUARTERLY REPORT EDGAR
19. Aug 15, 2022NT 10-Q EDGAR
20. Jun 17, 2022RW WITHDRAWAL REQUEST EDGAR

Every filing from the last five years, summarized. The full record is on SEC EDGAR.

Major holders

Investors who own more than 5% of the shares must tell the SEC: a 13D if they may seek to influence the company, a 13G if they hold passively.

• Radcliffe Capital Management, L.P.SC 13G/A, 2 filings Jan 27, 2023 to Feb 14, 2024²⁵
• GLAZER CAPITAL, LLCSC 13G, 1 filing Feb 14, 2023²⁶
• Goldman SachsSC 13G/A, 2 filings Feb 10, 2022 to Feb 14, 2023²⁷
• ARISTEIA CAPITAL, L.L.C.SC 13G/A, 2 filings Feb 14, 2022 to Feb 13, 2023²⁸
• Beryl Capital Management LLCSC 13G/A, 2 filings May 16, 2022 to Feb 13, 2023²⁹
• Hudson Bay Capital Management LPSC 13G, 1 filing Jan 25, 2023³⁰
• Atalaya Capital Management LPSC 13G/A, 2 filings Dec 14, 2021 to Feb 14, 2022³¹
• Biotech Sponsor LLCSC 13G, 1 filing Feb 14, 2022³²

SEC filer profile

How Biotech Acquisition Co is registered with the Securities and Exchange Commission, from its EDGAR record and the cover page of its latest annual report.

• Name on EDGARBiotech Acquisition Co¹
• CIK0001825413
• Filer status<br>emerging growth company¹
• Incorporated inCayman Islands¹
• Fiscal year endsDecember 31¹
• Industry code (SIC)6770 Blank Checks¹
• SEC reviewing officeOffice of Real Estate & Construction, Division of Corporation Finance¹
• Business address545 West 25Th Street, 20Th Floor, New York, NY 10001¹
• Phone8586920539¹
• Public float$222.4M as of Jun 30, 2021²
• On EDGAR sinceSep 21, 2020¹
• Filings132 in all: 425 (28), 8-K (27), CORRESP (9), SC 13G (9), UPLOAD (8), 10-Q (7), 3 (7), SC 13G/A (6)¹
  All 28 form types

  NT 10-Q (4), S-4/A (4), 10-K (2), 424B3 (2), DRS (2), EFFECT (2), S-1/A (2), 15-12G (1), 25-NSE (1), 424B4 (1), 8-A12B (1), 8-K/A (1), CERT (1), DEF 14A (1), DRS/A (1), DRSLTR (1), PRE 14A (1), RW (1), S-1 (1), S-4 (1)

• Latest filingsAnnual report (10-K) Mar 8, 2022
  Quarterly report (10-Q) Nov 22, 2022
  Proxy statement (DEF 14A) Jan 4, 2023
  Latest 8-K (8-K) Feb 2, 2023